GitHub Twitter


In we cannot find life science types (eg. protein, gene, biological pathway) except those types that overlap with healthcare and medicine domains defined by the health extension (eg. drug, artery). In previous meetings we discussed the benefits of of with several data providers but we also came with a list of concerns that need to be evaluated to be able to encourage data providers to adopt Bioschemas.

  1. Test the adoption of around a gene use case involving gene resources.
  2. Evaluating the issues and benefits about how to work with and Bioschemas


Group Leaders

Group Members